14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $2.30 $2.95 Wednesday, 1st May 2024 CLLS stock ended at $2.54. This is 0.94% less than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 2.52% from a day low at $2.54 to a day high of $2.60.
90 days $2.30 $3.13
52 weeks $0.96 $3.77

Historical Cellectis S.A. prices

Date Open High Low Close Volume
May 07, 2021 $16.08 $17.05 $15.81 $16.30 247 944
May 06, 2021 $16.65 $16.75 $15.36 $15.53 518 821
May 05, 2021 $17.25 $17.61 $16.59 $16.94 196 804
May 04, 2021 $17.91 $17.95 $16.95 $16.99 246 330
May 03, 2021 $18.71 $18.79 $17.97 $18.16 114 709
Apr 30, 2021 $19.29 $19.68 $18.35 $18.61 165 643
Apr 29, 2021 $19.42 $19.46 $18.62 $18.92 220 172
Apr 28, 2021 $19.49 $19.62 $18.85 $18.87 199 172
Apr 27, 2021 $20.42 $20.42 $19.81 $20.01 95 891
Apr 26, 2021 $19.31 $20.27 $19.31 $20.05 131 691
Apr 23, 2021 $19.06 $19.62 $19.01 $19.09 107 118
Apr 22, 2021 $18.91 $19.77 $18.83 $19.25 161 270
Apr 21, 2021 $18.20 $18.93 $18.01 $18.93 117 598
Apr 20, 2021 $18.31 $18.49 $17.70 $18.14 258 777
Apr 19, 2021 $19.42 $19.87 $18.64 $18.65 296 343
Apr 16, 2021 $19.63 $19.65 $18.95 $19.40 249 602
Apr 15, 2021 $19.82 $19.82 $19.11 $19.30 119 668
Apr 14, 2021 $19.41 $20.39 $19.41 $19.51 173 748
Apr 13, 2021 $18.93 $19.60 $18.85 $19.43 126 643
Apr 12, 2021 $19.45 $19.48 $18.50 $18.66 160 555
Apr 09, 2021 $19.94 $20.14 $19.50 $19.92 255 522
Apr 08, 2021 $19.81 $20.32 $19.17 $20.24 2 679 516
Apr 07, 2021 $19.91 $20.22 $19.12 $19.44 189 164
Apr 06, 2021 $20.23 $20.84 $19.66 $19.84 184 044
Apr 05, 2021 $20.32 $21.19 $20.04 $20.93 197 078
Click to get the best stock tips daily for free!

About Cellectis S.A.

Cellectis S.A. Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia; ALLO-501 and ALL... CLLS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT